The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Scheduling (national classification system) (8)
- Advertising (135)
- Regulatory compliance (72)
- COVID-19 (55)
- Prescription medicines (42)
- Therapeutic goods regulation (36)
- COVID-19 vaccines (26)
- Vaping hub (25)
- Compliance and enforcement hub (17)
- Import and export (12)
- Medicinal cannabis hub (11)
- Complementary medicines (8)
- Labelling and packaging (8)
- Legislation (7)
- Medicine safety (7)
- Over the counter (OTC) medicines (6)
- Safety (5)
- Alert/Advisory (4)
- Australian Register of Therapeutic Goods (ARTG) (4)
- Manufacturing (4)
- Non-prescription medicines (4)
- Shortages (4)
- Weight loss products (4)
- Cosmetics (2)
- Listed medicines (2)
- Medical devices safety (2)
- Assessed listed medicines (1)
- In Vitro Diagnostic medical devices (IVDs) (1)
Search
8 result(s) found, displaying 1 to 8
-
BlogIf your business sells or advertises paracetamol, then you need to be aware of the new rules around pack sizes that commence on 1 February 2025.
-
NoticesThis instrument is made under section 39 of the current Poisons Standard.
-
NoticesThis instrument is made under section 39 of the current Poisons Standard.
-
NoticesWe are providing a 12-month period of labelling exemptions for signal words for certain Pharmacy medicine and Pharmacist Only medicine products.
-
Media releasesThe TGA has published a final decision to reduce the maximum size of packs for various paracetamol products.
-
Media releasesFrom 1 June 2023, prescribing of oral ivermectin for ‘off-label’ uses will no longer be limited to specialists such as dermatologists, gastroenterologists and infectious diseases specialists.
-
Media releasesThe TGA has published an independent expert report examining the incidence of serious injury and death from intentional paracetamol overdose.
-
Media releasesToday the TGA announced a final decision to down-schedule certain low dose cannabidiol (CBD) preparations